Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Renews Gene Logic's Status as Certified Microarray Service Provider


NEW YORK (GenomeWeb News) - Gene Logic, an Ocimum Biosolutions company, said today that Agilent Technologies has renewed its status as a Certified Microarray Service Provider for Agilent gene expression microarrays.
 
Agilent’s Certified Service Provider program requires partners to pass a “rigorous assessment” on the company’s microarray platform, Gene Logic said.
 
Gene Logic was originally named an Agilent Certified Service provider in April 2007.
 
Ocimum acquired Gene Logic’s genomics business in December for $10 million.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.